IRVINE, Calif., June 16, 2009 (GLOBE NEWSWIRE) -- SectorWatch.biz announces the availability of a commentary of interest to investors in Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB) and other high-performance fiber equities making news and driving markets today. Investors can view our free commentaries at: www.SectorWatch.biz - in association with FiSpace.net, a dynamic social networking site for investors.
The allure of silk dates back many centuries likely because of silk's unique properties. The lowly silkworm, cultivated in China over 5,000 years ago, is commonly associated with silk production. But the silkworm isn't the only source of natural silk. In fact, spider silk is said to be one of the strongest natural fibers and actually has superior tensile strength and energy absorption properties. But an effective production methodology has eluded science . perhaps until now.
Enter Kraig Biocraft Laboratories, which is developing a way of inserting spider silk DNA directly into silkworms allowing the silkworms to produce the proteins for spider silk. This genetically-engineered spider silk could conceivably dominate the high performance fiber market, a market potentially worth billions.
A report titled "The New Silk Road" is available FREE at this link: http://www.usequitynews.com/news/the-new-silk.html
SectorWatch.biz is powered by Market Pathways, a leader in the representation of smallcap equities for nearly thirty years. Call us at the number below to have your company featured in our publications: SectorWatch.biz and StockUpTicks.com.
Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SectorWatch.biz is a property of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience. The subject companies have not always approved the statements made in this report. This report is neither a solicitation to buy nor an offer to sell securities but is for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor, analyst or licensed broker dealer and this report is not investment advice. J.A. Knepp CRD#2849651. MP has been paid fifteen hundred dollars by QualityStocks.net on behalf of Kraig Biocraft Laboratories for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding the subject company.